Medical network - on September 11, 2017 "the development of Chinese pharmaceutical market blue book released recently, the reporter understands, public hospital year-on-year decline in the terminal market share, sales growth rate also fell by 7.6%; Although the public primary medical sales volume is relatively small, it is the fastest growing market in the three terminals, and its market sales volume is 136 billion yuan. Some research institutions predict that the future public health drug market will be a "hot property" in the eyes of major pharmaceutical companies.
Public hospital terminal market share still ranks first
Statistics show that from 2011 to 2016, China's drug market terminal sales increased from 809.7 billion yuan to 14.975 billion yuan, and the compound growth rate was 13.08% in 6 years.
From the implementation of drug sales three terminal sales distribution, the first terminal terminal market share, the largest public hospital as drug sales is the most important terminal, the terminal sales of 1.024 trillion yuan in 2016, the share of 68.38%, but fell by 0.43% last year, compared to the sales growth also fell to 7.6%, down 3.1% year-on-year. Among them, the market of urban public hospital market reached 767.5 billion yuan, accounting for 51.3 percent of the national drug market, up 6.1 percent year on year and 9.7 percent in six years. The sales volume of county-level public hospitals reached 256.5 billion yuan, accounting for 17.1% of the national drug market, up 12.3% year on year, and the compound growth rate reached 14.1% in six years.
The number of pharmacies in the pharmacy market reached 332.7 billion
In the second terminal, retail pharmacy terminals include physical pharmacies and online pharmacies. Statistics show that in spite of its sales increased year by year, but the proportion of drug sales decline year by year, from 24.7% in 2011 to 22.54% in 2016 and 2016, compared with a year earlier share edged up 0.04%. Its 2016 terminal sales volume was 337.5 billion yuan.
Among them, the pharmaceutical market of the physical pharmacy reached 332.7 billion yuan, with the national drug market accounting for 22.2%, year-on-year growth of 8.1%, and a six-year compound growth rate of 8.9%. In the online pharmacy market, the sales volume of drugs in 2016 was 4.8 billion yuan, accounting for 0.33 percent, with a year-on-year growth of 50.0% and a six-year compound growth rate of 84.9 percent.
CFDA south medicine economic research institute, chief researcher Zhang Buyong analyzes believed that in early 2017, the state council announced the cancellation of the Internet drug trading services qualification B certificate, C certificate of approval, "which means legal medicine circulation enterprises around the world have the freedom to conduct the Internet drug B2B, B2C business, medicine, electricity development will be more and more flourish."
The market for public primary medical drugs has grown the most
The public primary medical terminal is the third terminal for drug sales. Although its sales volume is small, it is the fastest growing market in the three main terminals. Statistics show that its market share rose from 6.61% in 2011 to 9.08% in 2016, and its market sales volume was 130.6 billion yuan, with a growth rate of 13.2%.
With the deepening of public hospital reform and the promotion of the hierarchical medical system, the market share of the public primary medical terminal market is expected to continue to rise, zhang said. In public primary care terminal, including urban community health center/stand and two market towns and townships, the city community health center/stand market medicine worth RMB 50.1 billion in 2016, 3.3% of the national drug market, rose 14.3% year-on-year, the compound growth rate of 18.2% in six years.
"Pharmaceutical sales of urban community health center/stand still relatively small, but also gradually to the attention of the enterprise, in recent years, sales growth rate significantly faster than the growth rate of city public hospital pharmaceutical sales." Zhang Buyong introduction, on the other hand, benefit from the new medical reform policies, in towns and townships of pharmaceutical sales increase rapidly in recent years, the six year compound growth rate of 16.1%, far higher than urban public hospital pharmaceutical sales growth. Its market use is 85.9 billion yuan, with 5.7% of the national drug market, with a year-on-year growth rate of 12.6%.
|
